Sage Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Sage Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,251	Closed	-$1.03M	–	98
2019 Q1	$1.03M	Sell	9,251 -86	-0.9%	-$9.43K	0.66%	43
2018 Q4	$900K	Buy	9,337 +2	+0%	+$212	0.68%	43
2018 Q3	$1.14M	Buy	9,335 +519	+6%	+$61.1K	0.71%	39
2018 Q2	$968K	Hold	8,816	–	–	0.68%	44
2018 Q1	$941K	Buy	8,816 +87	+1%	+$9.64K	0.67%	43
2017 Q4	$932K	Buy	8,729 +149	+2%	+$15.9K	0.6%	47
2017 Q3	$954K	Buy	+8,580	New	+$917K	0.67%	43

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sage Capital Advisors's IBB Position: Q2 2019 in Review

Sage Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 9,251 shares — an estimated $1.03M sold.

Sage Capital Advisors first reported a position in IBB in Q3 2017 and held it in 7 quarters. The position peaked at $1.14M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Sage Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Sage Capital Advisors sold 9,251 iShares Biotechnology ETF shares in Q2 2019, an estimated $1.03M.
Sage Capital Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 7 quarters.
Sage Capital Advisors's iShares Biotechnology ETF position peaked at $1.14M in Q3 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Sage Capital Advisors's 13F filing for Q2 2019, filed 31 Jul 2019.